Literature DB >> 3473625

The gastrointestinal involvement in primary Sjögren's syndrome.

E B Tsianos, S Vasakos, A A Drosos, V D Malamou-Mitsi, H M Moutsopoulos.   

Abstract

Gastrointestinal manifestations in patients with primary Sjögren's syndrome (SS), which is an autoimmune exocrinopathy, include dysphagia, nausea, epigastric pain, dyspepsia and nutritional deficiencies. In this report, we are presenting the nature and incidence of esophageal, pancreatic and liver involvement in our primary SS patients. Esophageal motility was studied in 27 patients with primary SS and 25 normal age and sex matched volunteers. Esophageal dysfunction was detected in 11 of the 27 patients (40.71%). Individual analysis of the esophageal motility studies showed different patterns of esophageal dysfunction. These esophageal abnormalities did not correlate with the parotid flow rate, the degree of inflammatory infiltrate of the minor salivary glands, the extraglandular manifestations or the presence of autoantibodies. Sera from 25 patients with primary SS were studied for the total serum alpha-amylase activity and isoamylases. Sera from 81 normal age and sex matched volunteers were used as controls. None of these patients had abdominal pain or gastrointestinal symptoms at the time of blood collection. The presence of hyperamylasemia of P-type and S-type in 6/25 patients (24%) probably reflects a slow, subclinical, inflammatory process of the exocrine glands. Clinical and biochemical evaluation of the liver function was studied in 22 primary SS patients. One of them had abnormal liver function tests and another hepatomegaly and splenomegaly. Percutaneous liver biopsies in both revealed chronic active hepatitis.

Entities:  

Mesh:

Year:  1986        PMID: 3473625

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  8 in total

1.  Increased serum CA 19-9 antibodies in Sjögren's syndrome.

Authors:  R Safadi; M Ligumsky; E Goldin; Y Ilan; Y S Haviv; S Nusair
Journal:  Postgrad Med J       Date:  1998-09       Impact factor: 2.401

2.  Coeliac disease in Sjögren's syndrome--a study of 111 Hungarian patients.

Authors:  Peter Szodoray; Zsolt Barta; Gabriella Lakos; Szabolcs Szakáll; Margit Zeher
Journal:  Rheumatol Int       Date:  2003-09-17       Impact factor: 2.631

3.  A patient with a polyglandular autoimmune syndrome involving the salivary glands, thyroid, intestine, and pancreas.

Authors:  Alan L Buchman; Sambasiva M Rao
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

4.  Esophageal motor function in primary Sjögren's syndrome: correlation with dysphagia and xerostomia.

Authors:  M Anselmino; G Zaninotto; M Costantini; P Ostuni; A Ianniello; C Boccú; A Doria; S Todesco; E Ancona
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

5.  Manometric assessment of esophageal motility in patients with primary Sjögren's syndrome.

Authors:  Tufan Türk; Timur Pirildar; Ercan Tunç; Serhat Bor; Eker Doğanavşargil
Journal:  Rheumatol Int       Date:  2004-01-14       Impact factor: 2.631

6.  Esophageal motility disorders in patients with Sjögren's syndrome.

Authors:  R Palma; A Freire; J Freitas; A Morbey; T Costa; F Saraiva; F Queirós; A Carvalhinhos
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

7.  Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease.

Authors:  Kristofer Andréasson; Bodil Ohlsson; Thomas Mandl
Journal:  Arthritis Res Ther       Date:  2016-01-12       Impact factor: 5.156

8.  The liver is a common non-exocrine target in primary Sjögren's syndrome: a retrospective review.

Authors:  Mariana J Kaplan; Robert W Ike
Journal:  BMC Gastroenterol       Date:  2002-09-13       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.